National Comprehensive Cancer Network

Educational Events & Programs

NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business

Thursday, July 17, 2014
7:30 AM – 2:15 PM
(Breakfast and registration begin at 7:30 AM)

The Rittenhouse Hotel
Philadelphia, PA


Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.



Clifford Goodman, PhD
Senior Vice President
The Lewin Group


7:30 – 8:15 AM

8:20 – 8:25 AM
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

8:30 – 10:00 AM
Module I: How the ACA is Affecting NCCN Member Institutions: A Discussion with NCCN Best Practices Committee Members and Leadership on Changes in Strategies and Care Delivery

Edward J. Benz, Jr, MD
President and Chief Executive Officer
Dana-Farber/Brigham and Women’s Cancer Center

Shirley A. Johnson, RN, MS, MBA
Chief Nursing and Patient Care Services Officer
City of Hope Comprehensive Cancer Center

Maureen Kelly, RN, MS, OCN, NEA-BC
Vice President, Patient Care Services, Chief Nursing Officer
Roswell Park Cancer Institute

W. Thomas Purcell, MD, MBA
Associate Director for Clinical Services
Executive Medical Director, Oncology Services
University of Colorado Cancer Center

Warren Smedley, MSHA
Service Line Director, Cancer & GI Services
Executive Director, UAB Cancer Community Network
University of Alabama at Birmingham
Comprehensive Cancer Center

Ron S. Walters, MD, MBA, MHA, MS
Associate VP of Medical Operations & Informatics
Professor, Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

10:00 – 10:20 AM

10:25 AM – 11:35 PM
Module II: Health Plans and PBMs in the Exchanges— Approaches to Coverage for Cancer Treatment and the Effect ACA is Having on Access to Innovation (co-facilitated by Xcenda, LLC)
Amanda Forys, MSPH
Director, Reimbursement Strategy and Tactics
Xcenda, LLC

Allan Kogan, MD
Medical Director

Kara Suter, MS
Director, Payment Reform & Reimbursement
Vermont Health Access

Howard Wild, RPh
Vice President, Network and Generic Strategies

11:40 – 12:25 PM

12:30 – 2:00 PM
Module III: Meet the NCCN Guideline Experts – A Discussion of Guideline Changes Including the Inclusion of Cost, Biomarkers, Survivorship, and Recommendations for the Development of Relevant Clinical Trials    
Invited Panelists:
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

Toni K. Choueiri, MD (GU Cancers)
Clinical Director, Lank Center for Genitourinary Oncology
Director, Kidney Cancer Center
Associate Professor of Medicine, Harvard Medical School
Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

Crystal S. Denlinger, MD (Survivorship)
Assistant Professor
Fox Chase Cancer Center

Robert J. Morgan, Jr, MD (Ovarian Cancer)
Staff Physician, Department of Medical Oncology
City of Hope Comprehensive Cancer Center

Gregory A. Otterson, MD (Lung Cancer)
Professor of Internal Medicine
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

Alan P. Venook, MD (Colon Cancer)
Professor, Clinical Medicine
UCSF Helen Diller Family Comprehensive Cancer Center

2:05 – 2:15 PM                        
Closing Remarks     
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*Subject to change.

Program Location:

The Rittenhouse Hotel
210 W. Rittenhouse Square
Philadelphia, Pennsylvania 19103

Tuition Information:

 By 6.9.2014After 6.9.2014
Academy Alumni$795$895
Industry Registrants$1,195$1,295
NCCN Corporate Council Members$1,095$1,195
Ten or more people from the same company$1,050$1,050



As of Tuesday, June 10, 2014, the NCCN room block at the Rittenhouse Hotel is SOLD OUT. You may contact the hotel regarding availability outside of the NCCN room block. The hotel is not obligated to honor the NCCN discounted rate once the room block is sold out. Prevailing rates will apply.

Rittenhouse Hotel Reservations: 1-800-635-1042

Rooms reserved by people not registered as NCCN Academy attendees will be released immediately by the NCCN Conferences and Meetings Department.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.

License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.